TerminatedPhase 2NCT02867878

Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome

Studying Tako-Tsubo cardiomyopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital of Ferrara
Principal Investigator
Matteo Tebaldi, MD
Azienda Ospedaliera Universitria di Ferrara
Intervention
Adenosine(drug)
Enrollment
5 target
Eligibility
18 years · All sexes
Timeline
20162018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02867878 on ClinicalTrials.gov

Other trials for Tako-Tsubo cardiomyopathy

Additional recruiting or active studies for the same condition.

See all trials for Tako-Tsubo cardiomyopathy

← Back to all trials